What's breaking now, across thousands of outlets.
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
A large and well-known retail pharmacy giant is planning to split into two companies as part of a new strategic direction.
Key PointsTake-Two reported lackluster results for the quarter.
The US dollar gained against most major currencies after inflation data exceeded forecasts, fueling expectations of a rate hike next month.
Hotter U.S. consumer prices lifted bets on a December Fed rate increase, with a small chance priced in for a half-point move
Nuclear weapons depend on elaborate safeguards intended to prevent unauthorized use while ensuring retaliation remains possible.
(RTTNews) - Novartis AG (NVS, NOVN.SW) on Tuesday reported encouraging two-year results from its ongoing Phase 3 NEPTUNUS extension study of investigational drug ianalumab, showing further…
